Use of Dexmedetomidine and Opioids in Hospitalized Preterm Infants

IMPORTANCE: Dexmedetomidine, an α(2)-adrenergic agonist, is not approved by the Food and Drug Administration for use in premature infants. However, the off-label use of dexmedetomidine in premature infants has increased 50-fold in the past decade. Currently, there are no large studies characterizing...

Descripción completa

Detalles Bibliográficos
Autores principales: Curtis, Samantha, Kilpatrick, Ryan, Billimoria, Zeenia C., Zimmerman, Kanecia, Tolia, Veeral, Clark, Reese, Greenberg, Rachel G., Puia-Dumitrescu, Mihai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625033/
https://www.ncbi.nlm.nih.gov/pubmed/37921767
http://dx.doi.org/10.1001/jamanetworkopen.2023.41033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625033/
https://www.ncbi.nlm.nih.gov/pubmed/37921767
http://dx.doi.org/10.1001/jamanetworkopen.2023.41033

Ejemplares similares